MNTS Stock Eyes Best Month Ever After Former Astronaut Buys Shares — Traders Bet On SpaceX IPO Spillover

Momentus shares have surged 234% this month and more than doubled on Tuesday after former astronaut and director Chris Hadfield bought 2,000 shares at $7.19, lifting his stake to 3,500 shares. The company also highlighted a 2026 revenue forecast of $10 million versus $1.1 million last year and recent Vigoride 7 payload activity tied to NASA, DARPA and defense contracts. Separate SpaceX IPO buzz is amplifying speculative interest in smaller space names, reinforcing the rally.

Analysis

MNTS is being traded less as a standalone operating story and more as a convex beta proxy on the SpaceX rerating narrative. That matters because the market is rewarding any credible linkage to launch cadence, defense payloads, or insider alignment, even if the underlying business is still too small to justify the move on fundamentals alone. In other words, this is a sentiment-driven float squeeze layered on top of a “space stack” repricing, and those regimes can persist longer than fundamentals allow but tend to reverse abruptly once incremental buyers run out.

The bigger second-order effect is that SpaceX’s IPO process could lift the valuation floor for every adjacent public-space name, but the benefits will be uneven. Companies with real launch access, defense-related payload exposure, or embedded credibility with institutional allocators should outperform the pure retail/speculative names because they can convert attention into follow-on capital and contract win-rate. MNTS likely sees the most torque in the near term, but that torque also creates financing overhang risk: a shelf in a vertical move often becomes a source of supply once volatility normalizes.

The key risk is timing mismatch. The market can keep pricing the SpaceX optionality for days to weeks, while the actual monetization path for smaller peers is months to years and may never materialize. If the broader market stops rewarding “space adjacency,” or if SpaceX listing timing slips, MNTS could give back a large fraction of the move quickly because there is little underlying scale to anchor the multiple.

The contrarian read is that the move is likely overextended versus any near-term fundamental inflection. Insider buying is supportive, but in microcaps it often signals confidence in survival rather than an imminent inflection in earnings power. The better expression may not be outright long MNTS here, but owning the spillover with higher-quality names and using MNTS only as a short-dated momentum trade.

Key Decisions for Investors

• Reduce outright long exposure to MNTS after the vertical move; if holding, use a 1-3 week trailing stop or trim 50-70% into strength because the rally is sentiment-led and highly reversible.
• For tactical momentum, buy MNTS call spreads or a small common stock starter only on pullbacks of 10-15% intraday; target a 2:1 to 3:1 upside/downside over 5-10 trading days, with defined premium risk.
• Prefer a pair trade: long higher-quality space/defense enablers with contract visibility versus short MNTS or another speculative peer, holding 1-3 months to capture the re-rating while avoiding the weakest balance sheet.
• Watch for shelf-registration follow-on supply in the next 2-8 weeks; if trading volume stays elevated while price stalls, fade the move because financing risk becomes the dominant overhang.
• If SpaceX IPO headlines intensify, rotate exposure from MNTS into names with actual launch/defense revenue linkage for a cleaner risk/reward profile; the market will likely reward credibility over pure adjacency once the initial frenzy peaks.